生命科学资讯

Roche's patent deal with Structure; AstraZeneca reports lupus data

Protagonist 'strongly leaning' toward opting out of Takeda profit-sharing deal

Lilly goes back to Nimbus for an oral obesity drug in $55M deal

Arrowhead’s RNAi obesity programs head to Phase 2 after encouraging early data

Appeals court rules against NIH’s indirect cost cut plan

FDA raises new questions with Sanofi's MS drug in release of rejection letter

HHS urges Supreme Court to decline AstraZeneca's petition over Medicare price negotiations

US to stop recommending six vaccines for all kids, prioritizing individual choice and higher-risk groups

Crinetics reports robust full-quarter sales for rare disease drug Palsonify

Zenas BioPharma’s Phase 3 autoimmune disease readout disappoints

Moderna seeks flu vaccine approvals; Neumora Alzheimer's data

Argenx to elevate Massey to CEO as it expands rare disease business

Sanofi doubles down on Earendil in $160M near-term deal

Aktis Oncology eyes $181M listing to start industry’s anticipated IPO rebound

Comanche gets $40M more to test its preeclampsia siRNA

Servier taps Insilico’s AI platform for early cancer R&D

Novo Nordisk launches Wegovy pill at $25 per month for insured patients, $149 cash

AbbVie does T cell engager deal in China for Zelgen's DLL3-targeted drug

Vanda wins FDA approval for motion sickness drug

FDA rejects Corcept’s cortisol-targeting drug for Cushing’s syndrome